DATE: December 10, 2025
TIME: 10:00 am a 12:0 am (EST).
LANGUAGES: English and Spanish with simultaneous interpretation.
Substandard and falsified medical products continue to pose a significant threat to global public health, affecting patient safety, treatment effectiveness, and trust in health systems. The proliferation of these products, driven by complex supply chains and cross-border digital trade, demands innovative, collaborative, and sustainable responses.
The integration of new tools—such as artificial intelligence, advanced analytics, participatory surveillance, and digital traceability systems—offers unprecedented opportunities to improve early detection, information sharing, and coordinated action among regulatory authorities, academic institutions, and strategic partners.
Register for this regional seminar to learn more about best practices, partnerships, and technological solutions that strengthen regional capacity to anticipate, manage, and mitigate risks associated with substandard and falsified products.
Agenda:
From agreements to action: international cooperation against cross-border threats
Global governance and regulatory cooperation. Substandard and falsified products do not recognize borders. Mechanisms to strengthen cooperation among regulatory authorities, customs, prosecutors, and international networks will be analyzed.
-Strengthening surveillance of substandard and falsified products in the Americas: collaborative experience among countries. Robin Rojas-Cortes, PAHO/WHO
- Collaborative action among countries to address the sale of substandard and falsified medical products online. INVIMA
- Interinstitutional actions to address substandard and falsified medical products. Felipe González, ISP-Chile
- The role of the Caribbean Regulatory System (CRS) in addressing substandard and falsified products detected within the Caribbean region. Dr. Chantelle Bailey, Programme Manager - Caribbean Regulatory System (CRS)
From detection to prediction: artificial intelligence and advanced analytics to combat substandard and falsified products
Technological innovation and prospective surveillance. Explore how artificial intelligence, machine learning, and advanced analytics can transform early detection and response to substandard and falsified products.
- From detection to prediction: artificial intelligence and advanced analytics. PAHO/WHO
- DAFODIL dashboard. Céline Caillet Deputy Head of the Medicine Quality Research Group, Nuffield Department of Medicine, University of Oxford
Regulation 4.0: collaborative surveillance and citizen participation
Social innovation and technology. Success stories in mobile apps, crowdsourcing, and participatory surveillance to detect falsified products in real time, with impact on public education and local response.
- ARCSA Móvil: citizen participation and technology in detecting falsified products in Ecuador. Danny Llerena, Ecuador ARCSA